To elucidate the mechanisms underpinning E-cadherin’s diverse SL interactions and the subsequent vulnerabilities in CDH1-null cancers, we have now extended our analysis of isogenic cell line pairs and applied a novel bioinformatic approach that statistically queries tumour genome-wide expression data for potential SL pathways. The gene discussed is CDH1; the disease is neoplasm.